Business
New Gold-Based Drug Slows Cancer Tumor Growth By 82%, Outperforms Chemotherapy
A groundbreaking gold-based drug developed by RMIT University and leading Indian institutions is showing exceptional promise in slowing cancer tumor growth by 82%, surpassing traditional chemotherapy treatments. This revolutionary discovery offers new hope for cancer patients worldwide.